Dr. Lonial is Executive Vice Chair, Chief Medical Officer and Professor in the Department of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University, where he is also Vice Chair of Clinical Affairs for the department, and Director of the Translational Research B-Cell Malignancy Program. He earned his medical degree from the University of Louisville School Of Medicine in Kentucky. He completed his internship and residency, and chief residency at Baylor College of Medicine in Houston, Texas, followed by a fellowship in Hematology/Oncology at Emory University School of Medicine in Atlanta, Georgia. Dr Lonial’s research focuses on combination therapy in B-cell malignancies focusing on myeloma. He is a trained bone marrow transplant physician with an interest in molecular therapy for lymphoma and myeloma. His clinical interests include evaluating the combination of new molecular targeted agents for B-cell cancers, as well as methods to enhance immunity following allogeneic or autologous stem cell transplant. Dr Lonial is a member of several local committees as well as a member of several committees for the American Society of Hematology. He is also involved in numerous professional organizations including the American Society of Clinical Oncology and the American Society for Blood and Marrow Transplantation. In addition, he serves on the editorial board of Journal of Clinical Oncology, Leukemia, and is the myeloma editor for Clinical Lymphoma, Myeloma, and Leukemia. and as an invited or ad hoc reviewer for several publications, including Blood, and Haematologica, Clinical Cancer Research, NEJM, and others. Dr Lonial has authored or coauthored over 150 publications and abstracts and has given several presentations, locally, nationally, and internationally.
By Eliot Finkelstein